The University of Cambridge says it successfully tested a vaccine with an AI-designed antigen

Article excerpt

Researchers at the University of Cambridge have successfully tested the first vaccine whose antigen was designed entirely by artificial intelligence. The breakthrough marks a significant milestone in computational biology, demonstrating that AI can accelerate the vaccine development process by identifying promising molecular structures without human intervention. The team used machine learning algorithms to design the antigen, then validated it in laboratory tests. While early-stage, the achievement suggests AI could dramatically speed up responses to future disease outbreaks by compressing what normally takes months of human research into days of computational analysis.